Dysbiotic gut microbes may contribute to hypertension by limiting vitamin D production

Accumulating studies have suggested that gut microbiota (GM) dysbiosis and vitamin D3 deficiency each play an important role during the progression of hypertension (HTN). However, few studies have characterized the underlying interaction between GM shift and vitamin D3 deficiency in HTN patients.

[1]  Yan Guo,et al.  Unilateral ureteral obstruction causes gut microbial dysbiosis and metabolome disorders contributing to tubulointerstitial fibrosis , 2019, Experimental & Molecular Medicine.

[2]  Yan Guo,et al.  Microbiome–metabolome reveals the contribution of gut–kidney axis on kidney disease , 2019, Journal of Translational Medicine.

[3]  R. Qayyum,et al.  Association between serum vitamin D levels and cardiorespiratory fitness in the adult population of the USA , 2018, European journal of preventive cardiology.

[4]  Corrigendum to: 2018 ESC/ESH Guidelines for the management of arterial hypertension. , 2018, European heart journal.

[5]  H. Tun,et al.  Meta-analysis of effects of exclusive breastfeeding on infant gut microbiota across populations , 2018, Nature Communications.

[6]  H. Qin,et al.  Dysbiosis signatures of gut microbiota in coronary artery disease. , 2018, Physiological genomics.

[7]  I. Lambrinoudaki,et al.  Vitamin D and cardiovascular disease. , 2018, Maturitas.

[8]  G. Lip,et al.  2018 ESC/ESH Guidelines for the management of arterial hypertension. , 2018, European heart journal.

[9]  Massimo Mangino,et al.  Gut microbial diversity is associated with lower arterial stiffness in women , 2018, European heart journal.

[10]  B. Kreikemeyer,et al.  Vitamin D administration leads to a shift of the intestinal bacterial composition in Crohn's disease patients, but not in healthy controls , 2018, Journal of digestive diseases.

[11]  A. Patterson,et al.  The Gut Microbiota Regulates Endocrine Vitamin D Metabolism through Fibroblast Growth Factor 23 , 2018, Front. Immunol..

[12]  Joseph L Evans,et al.  Role of gut microbiota and oxidative stress in the progression of non-alcoholic fatty liver disease to hepatocarcinoma: Current and innovative therapeutic approaches , 2018, Redox biology.

[13]  B. Geng,et al.  Metagenomic and metabolomic analyses unveil dysbiosis of gut microbiota in chronic heart failure patients , 2018, Scientific Reports.

[14]  S. Hazen,et al.  Microbial modulation of cardiovascular disease , 2018, Nature Reviews Microbiology.

[15]  W. Tang,et al.  Gut Microbiota and Atherosclerosis , 2017, Current Atherosclerosis Reports.

[16]  Hui Huang,et al.  A novel role of cellular interactions in vascular calcification , 2017, Journal of Translational Medicine.

[17]  M. Gladwin,et al.  Enterosalivary nitrate metabolism and the microbiome: Intersection of microbial metabolism, nitric oxide and diet in cardiac and pulmonary vascular health , 2017, Free radical biology & medicine.

[18]  S. Hazen,et al.  Gut Microbiota in Cardiovascular Health and Disease , 2017, Circulation research.

[19]  Weili Zhang,et al.  Gut microbiota dysbiosis contributes to the development of hypertension , 2017, Microbiome.

[20]  W. D. de Vos,et al.  Comparative genomics and physiology of the butyrate-producing bacterium Intestinimonas butyriciproducens. , 2016, Environmental microbiology reports.

[21]  Jana G Hashash,et al.  Association of Vitamin D Level With Clinical Status in Inflammatory Bowel Disease: A 5-Year Longitudinal Study , 2016, The American Journal of Gastroenterology.

[22]  Morris A. Swertz,et al.  Population-based metagenomics analysis reveals markers for gut microbiome composition and diversity , 2016, Science.

[23]  R. Blachman-Braun,et al.  Vitamin D and its effects on cardiovascular diseases: a comprehensive review , 2016, The Korean journal of internal medicine.

[24]  S. Anderson,et al.  Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis , 2016, The Lancet.

[25]  D. Agrawal,et al.  Vitamin D deficiency and essential hypertension. , 2015, Journal of the American Society of Hypertension : JASH.

[26]  P. Jose,et al.  Gut microbiota in hypertension , 2015, Current opinion in nephrology and hypertension.

[27]  D. Gardner,et al.  Elimination of Vitamin D Receptor in Vascular Endothelial Cells Alters Vascular Function , 2014, Hypertension.

[28]  M. Cantorna,et al.  Vitamin D, immune regulation, the microbiota, and inflammatory bowel disease , 2014, Experimental biology and medicine.

[29]  H. Sokol,et al.  Faecalibacterium prausnitzii and human intestinal health. , 2013, Current opinion in microbiology.

[30]  J. Gordon,et al.  Olfactory receptor responding to gut microbiota-derived signals plays a role in renin secretion and blood pressure regulation , 2013, Proceedings of the National Academy of Sciences.

[31]  D. Towler,et al.  Arterial calcification and bone physiology: role of the bone–vascular axis , 2012, Nature Reviews Endocrinology.

[32]  Kuibao Li,et al.  Prevalence of Ideal Cardiovascular Health and Its Relationship With the 4-Year Cardiovascular Events in a Northern Chinese Industrial City , 2012, Circulation. Cardiovascular quality and outcomes.

[33]  D. Eyles,et al.  Vitamin D insufficiency is associated with impaired vascular endothelial and smooth muscle function and hypertension in young rats , 2011, The Journal of physiology.

[34]  C. Sigmund,et al.  Increased Renin Production in Mice With Deletion of Peroxisome Proliferator-Activated Receptor-&ggr; in Juxtaglomerular Cells , 2010, Hypertension.

[35]  O. Franco,et al.  Levels of vitamin D and cardiometabolic disorders: systematic review and meta-analysis. , 2010, Maturitas.

[36]  S. Silverberg,et al.  Parathyroid hormone and the cardiovascular system , 2008, Current osteoporosis reports.

[37]  D. Harrison,et al.  Role of the T cell in the genesis of angiotensin II–induced hypertension and vascular dysfunction , 2007, The Journal of experimental medicine.

[38]  J. Schölmerich,et al.  Ablation of the sympathetic nervous system decreases gram-negative and increases gram-positive bacterial dissemination: key roles for tumor necrosis factor/phagocytes and interleukin-4/lymphocytes. , 2005, The Journal of infectious diseases.

[39]  Y. Takeuchi,et al.  FGF‐23 Is a Potent Regulator of Vitamin D Metabolism and Phosphate Homeostasis , 2003, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[40]  Shu Q. Liu,et al.  1,25-Dihydroxyvitamin D3 is a negative endocrine regulator of the renin-angiotensin system , 2002 .

[41]  H. Hulter,et al.  Chronic continuous PTH infusion results in hypertension in normal subjects. , 1986, Journal of clinical hypertension.

[42]  Shu Q. Liu,et al.  1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system. , 2002, The Journal of clinical investigation.